Recro Pharma Added to the Russell 3000® Index
MALVERN, Pa., June 26, 2017 (GLOBE NEWSWIRE) -- Recro Pharma, Inc. (Nasdaq:REPH), a revenue generating specialty pharmaceutical company focused on therapeutics for hospital and other acute care settings, today announced that it was added to the Russell …